Innovent Biologics, Inc. (IVBXF)
Develops and sells antibody drugs treating cancer, autoimmune diseases, and other conditions in China and globally.
$10.86-0.15%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+2.1%
The outlook
IVBXF is trading near its 52-week low and above both its 50- and 200-day moving averages, showing a modest upward technical position. The stock carries a notably high trailing P/E of 135.8, reflecting limited current profitability. Overall sentiment leans bullish, though the price remains in the lower half of its annual range.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range29% of the way from its 52-week low to high
Market cap
$18.91B
52-wk high
$15.12
52-wk low
$9.10
50-day avg
$10.62
200-day avg
$10.84
Trailing P/E
135.8